{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:12:52Z","timestamp":1785222772417,"version":"3.55.0"},"reference-count":53,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0489","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":22,"title":["Angioedema"],"prefix":"10.3238","author":[{"given":"Janina","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Nordmann-Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Trainotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"10.3238\/arztebl.2017.0489_ref1","doi-asserted-by":"crossref","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al.: A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med 2014; 21: 469\u201384","DOI":"10.1111\/acem.12341"},{"key":"10.3238\/arztebl.2017.0489_ref2","doi-asserted-by":"crossref","unstructured":"Ring J, Beyer K, Biedermann T, et al.: Guideline for acute therapy and management of anaphylaxis. Allergo J Int 2014; 23: 96\u2013112","DOI":"10.1007\/s40629-014-0009-1"},{"key":"10.3238\/arztebl.2017.0489_ref3","doi-asserted-by":"crossref","unstructured":"Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G: Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443\u201351","DOI":"10.1111\/j.1398-9995.2005.00785.x"},{"key":"10.3238\/arztebl.2017.0489_ref4","doi-asserted-by":"crossref","unstructured":"Worm M, Edenharter G, Rueff F, et al.: Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691\u20138","DOI":"10.1111\/j.1398-9995.2012.02795.x"},{"key":"10.3238\/arztebl.2017.0489_ref5","doi-asserted-by":"crossref","unstructured":"Banerji A, Oren E, Hesterberg P, Hsu Y, Camargo CA, Jr, Wong JT: Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy\/immunology consult service. Allergy Asthma Proc 2008; 29: 88\u201392","DOI":"10.2500\/aap2008.29.3085"},{"key":"10.3238\/arztebl.2017.0489_ref6","doi-asserted-by":"crossref","unstructured":"Javaud N, Charpentier S, Lapostolle F, et al.: Angiotensin-converting enzyme inhibitor-induced angioedema and hereditary angioedema: a comparison study of attack severity. Intern Med 2015; 54: 2583\u20138","DOI":"10.2169\/internalmedicine.54.4181"},{"key":"10.3238\/arztebl.2017.0489_ref7","doi-asserted-by":"crossref","unstructured":"Bas M, Greve J, Stelter K, et al.: A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med 2015; 372: 418\u201325","DOI":"10.1056\/NEJMoa1312524"},{"key":"10.3238\/arztebl.2017.0489_ref8","doi-asserted-by":"crossref","unstructured":"McDowell SE, Coleman JJ, Ferner RE: Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332: 1177\u201381","DOI":"10.1136\/bmj.38803.528113.55"},{"key":"10.3238\/arztebl.2017.0489_ref9","doi-asserted-by":"crossref","unstructured":"Bas M, Greve J, Strassen U, Khosravani F, Hoffmann TK, Kojda G: Angioedema induced by cardiovascular drugs. New players join old friends. Allergy 2015; 70: 1196\u2013200","DOI":"10.1111\/all.12680"},{"key":"10.3238\/arztebl.2017.0489_ref10","doi-asserted-by":"crossref","unstructured":"Craig T, Aygoren-Pursun E, Bork K, et al.: WAO guideline for the management of hereditary angioedema. World Allergy Organ J 2012; 5: 182\u201399","DOI":"10.1097\/WOX.0b013e318279affa"},{"key":"10.3238\/arztebl.2017.0489_ref11","doi-asserted-by":"crossref","unstructured":"Papadopoulou-Alataki E: Upper airway considerations in hereditary angioedema. Curr Opin Allergy Clin Immunol 2010; 10: 20\u20135","DOI":"10.1097\/ACI.0b013e328334f629"},{"key":"10.3238\/arztebl.2017.0489_ref12","doi-asserted-by":"crossref","unstructured":"Bork K, Staubach P, Hardt J: Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema. Allergy 2008; 63: 751\u20137","DOI":"10.1111\/j.1398-9995.2007.01577.x"},{"key":"10.3238\/arztebl.2017.0489_ref13","doi-asserted-by":"crossref","unstructured":"Busse PJ, Buckland MS: Non-histaminergic angioedema: focus on bradykinin-mediated angioedema. Clin Exp Allergy 2013; 43: 385\u201394","DOI":"10.1111\/cea.12019"},{"key":"10.3238\/arztebl.2017.0489_ref14","doi-asserted-by":"crossref","unstructured":"Panesar SS, Javad S, de Silva D, et al.: The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68: 1353\u201361","DOI":"10.1111\/all.12272"},{"key":"10.3238\/arztebl.2017.0489_ref15","doi-asserted-by":"crossref","unstructured":"Maurer M, Bader M, Bas M, et al.: New topics in bradykinin research. Allergy 2011; 66: 1397\u2013406","DOI":"10.1111\/j.1398-9995.2011.02686.x"},{"key":"10.3238\/arztebl.2017.0489_ref16","doi-asserted-by":"crossref","unstructured":"Steiner UC, Weber-Chrysochoou C, Helbling A, Scherer K, Grendelmeier PS, Wuillemin WA: Hereditary angioedema due to C1\u2014inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study. Orphanet J Rare Dis 2016; 11: 43","DOI":"10.1186\/s13023-016-0423-1"},{"key":"10.3238\/arztebl.2017.0489_ref17","doi-asserted-by":"crossref","unstructured":"Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G: Nonallergic angioedema: role of bradykinin. Allergy 2007; 62: 842\u201356","DOI":"10.1111\/j.1398-9995.2007.01427.x"},{"key":"10.3238\/arztebl.2017.0489_ref18","doi-asserted-by":"crossref","unstructured":"Cicardi M, Banerji A, Bracho F, et al.: Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363: 532\u201341","DOI":"10.1056\/NEJMx100067"},{"key":"10.3238\/arztebl.2017.0489_ref19","unstructured":"Dispenza MC, Gutierrez M, Bajaj P, Craig TJ: The need for individualized hereditary angioedema acute action plans: Two case studies of misdiagnosed attacks and unnecessary surgeries. The Journal of Angioedema 2013; 1\u20134."},{"key":"10.3238\/arztebl.2017.0489_ref20","doi-asserted-by":"crossref","unstructured":"Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A: Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982; 284: 2\u20139","DOI":"10.1097\/00000441-198207000-00001"},{"key":"10.3238\/arztebl.2017.0489_ref21","doi-asserted-by":"crossref","unstructured":"Makani H, Messerli FH, Romero J, et al.: Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 2012; 110: 383\u201391","DOI":"10.1016\/j.amjcard.2012.03.034"},{"key":"10.3238\/arztebl.2017.0489_ref22","doi-asserted-by":"crossref","unstructured":"Beltrami L, Zingale LC, Carugo S, Cicardi M: Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it. Expert Opin Drug Saf 2006; 5: 643\u20139","DOI":"10.1517\/14740338.5.5.643"},{"key":"10.3238\/arztebl.2017.0489_ref23","doi-asserted-by":"crossref","unstructured":"Bas M, Kojda G, Bier H, Hoffmann TK: ACE inhibitor-induced angioedema in the head and neck region. A matter of time? HNO 2004; 52: 886\u201390","DOI":"10.1007\/s00106-003-1017-5"},{"key":"10.3238\/arztebl.2017.0489_ref24","doi-asserted-by":"crossref","unstructured":"Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr: Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008; 100: 327\u201332","DOI":"10.1016\/S1081-1206(10)60594-7"},{"key":"10.3238\/arztebl.2017.0489_ref25","doi-asserted-by":"crossref","unstructured":"Dean DE, Schultz DL, Powers RH: Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001; 46: 1239\u201343","DOI":"10.1520\/JFS15129J"},{"key":"10.3238\/arztebl.2017.0489_ref26","doi-asserted-by":"crossref","unstructured":"Faisant C, Armengol G, Bouillet L, et al.: Angioedema triggered by medication blocking the renin\/angiotensin system: retrospective study using the French national pharmacovigilance database. J Clin Immunol 2016; 36: 95\u2013102","DOI":"10.1007\/s10875-015-0228-3"},{"key":"10.3238\/arztebl.2017.0489_ref27","doi-asserted-by":"crossref","unstructured":"Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M: Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 2011; 29: 2273\u20137","DOI":"10.1097\/HJH.0b013e32834b4b9b"},{"key":"10.3238\/arztebl.2017.0489_ref28","doi-asserted-by":"crossref","unstructured":"Scully C, Langdon J, Evans J: Marathon of eponyms: 17 Quincke oedema (Angioedema). Oral Dis 2011; 17: 342\u20134","DOI":"10.1111\/j.1601-0825.2009.01549.x"},{"key":"10.3238\/arztebl.2017.0489_ref29","doi-asserted-by":"crossref","unstructured":"Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178: 2123\u201330","DOI":"10.1084\/jem.178.6.2123"},{"key":"10.3238\/arztebl.2017.0489_ref30","doi-asserted-by":"crossref","unstructured":"Shimamura T, Shiroishi M, Weyand S, et al.: Structure of the human histamine H1 receptor complex with doxepin. Nature 2011; 475: 65\u201370","DOI":"10.1038\/nature10236"},{"key":"10.3238\/arztebl.2017.0489_ref31","doi-asserted-by":"crossref","unstructured":"Simons FE: Advances in H1-antihistamines. N Engl J Med 2004; 351: 2203\u201317","DOI":"10.1056\/NEJMra033121"},{"key":"10.3238\/arztebl.2017.0489_ref32","doi-asserted-by":"crossref","unstructured":"Akdis CA, Simons FE: Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006; 533: 69\u201376","DOI":"10.1016\/j.ejphar.2005.12.044"},{"key":"10.3238\/arztebl.2017.0489_ref33","doi-asserted-by":"crossref","unstructured":"Smit MJ, Hoffmann M, Timmerman H, Leurs R: Molecular properties and signalling pathways of the histamine H1 receptor. Clin Exp Allergy 1999; 29 (Suppl 3): 19\u201328","DOI":"10.1046\/j.1365-2222.1999.00007.x-i1"},{"key":"10.3238\/arztebl.2017.0489_ref34","doi-asserted-by":"crossref","unstructured":"Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M: Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol 2017; 139: 1772\u201381","DOI":"10.1016\/j.jaci.2016.08.050"},{"key":"10.3238\/arztebl.2017.0489_ref35","doi-asserted-by":"crossref","unstructured":"Greve J, Bas M, Hoffmann TK, et al.: Effect of C1-esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope 2015; 125: E198\u2013202","DOI":"10.1002\/lary.25113"},{"key":"10.3238\/arztebl.2017.0489_ref36","doi-asserted-by":"crossref","unstructured":"Dray A, Perkins M: Bradykinin and inflammatory pain. Trends Neurosci 1993; 16: 99\u2013104","DOI":"10.1016\/0166-2236(93)90133-7"},{"key":"10.3238\/arztebl.2017.0489_ref37","doi-asserted-by":"crossref","unstructured":"Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ: Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002; 39: 460\u20134","DOI":"10.1161\/hy0202.103054"},{"key":"10.3238\/arztebl.2017.0489_ref38","doi-asserted-by":"crossref","unstructured":"Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A: Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002; 359: 2088\u20139","DOI":"10.1016\/S0140-6736(02)08914-6"},{"key":"10.3238\/arztebl.2017.0489_ref39","doi-asserted-by":"crossref","unstructured":"Bas M, Greve J, Stelter K, et al.: A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med 2015; 372: 418\u201325","DOI":"10.1056\/NEJMoa1312524"},{"key":"10.3238\/arztebl.2017.0489_ref40","doi-asserted-by":"crossref","unstructured":"Wirth K, Hock FJ, Albus U, et al.: Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 1991; 102: 774\u20137","DOI":"10.1111\/j.1476-5381.1991.tb12249.x"},{"key":"10.3238\/arztebl.2017.0489_ref41","doi-asserted-by":"crossref","unstructured":"Pappalardo E, Cicardi M, Duponchel C, et al.: Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 2000; 106: 1147\u201354","DOI":"10.1067\/mai.2000.110471"},{"key":"10.3238\/arztebl.2017.0489_ref42","doi-asserted-by":"crossref","unstructured":"Kaplan AP, Greaves MW: Angioedema. J Am Acad Dermatol 2005; 53: 373\u201388; quiz 389\u201392","DOI":"10.1016\/j.jaad.2004.09.032"},{"key":"10.3238\/arztebl.2017.0489_ref43","doi-asserted-by":"crossref","unstructured":"Dewald G, Bork K: Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006; 343: 1286\u20139","DOI":"10.1016\/j.bbrc.2006.03.092"},{"key":"10.3238\/arztebl.2017.0489_ref44","doi-asserted-by":"crossref","unstructured":"Hahn J, Bas M, Hoffmann TK, Greve J: Bradykinin-induced angioedema: definition, pathogenesis, clinical presentation, diagnosis and therapy. HNO 2015; 63: 885\u201393; quiz 894\u20135","DOI":"10.1007\/s00106-015-0084-8"},{"key":"10.3238\/arztebl.2017.0489_ref45","doi-asserted-by":"crossref","unstructured":"Cicardi M, Bellis P, Bertazzoni G, et al.: Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med 2014; 9: 85\u201392","DOI":"10.1007\/s11739-013-0993-z"},{"key":"10.3238\/arztebl.2017.0489_ref46","doi-asserted-by":"crossref","unstructured":"Worm M, Reese I, Ballmer-Weber B, et al.: Leitlinie zum Management IgE-vermittelter Nahrungsmittelallergien. Allergo J Int 2015; 24: 256","DOI":"10.1007\/s15007-015-0983-8"},{"key":"10.3238\/arztebl.2017.0489_ref47","unstructured":"Worm M, Eckermann O, Dolle S, et al.: Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int 2014; 111: 367\u201375"},{"key":"10.3238\/arztebl.2017.0489_ref48","doi-asserted-by":"crossref","unstructured":"Ring J, Grosber M, Mohrenschlager M, Brockow K: Anaphylaxis: acute treatment and management. Chem Immunol Allergy 2010; 95: 201\u201310","DOI":"10.1159\/000315953"},{"key":"10.3238\/arztebl.2017.0489_ref49","doi-asserted-by":"crossref","unstructured":"Bork K, Maurer M, Bas M, et al.: Leitlinie \u201eHeredit\u00e4res Angio\u00f6dem durch C1 Inhibitor Mangel\u201c 2012. AWMF-Register-Nr. 061-029.","DOI":"10.1007\/s15007-012-0046-3"},{"key":"10.3238\/arztebl.2017.0489_ref50","doi-asserted-by":"crossref","unstructured":"Li HH, Moldovan D, Bernstein JA, et al.: Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. J Allergy Clin Immunol Pract 2015; 3: 417\u201323","DOI":"10.1016\/j.jaip.2014.12.013"},{"key":"10.3238\/arztebl.2017.0489_ref51","doi-asserted-by":"crossref","unstructured":"Craig TJ, Levy RJ, Wasserman RL, et al.: Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009; 124: 801\u20138","DOI":"10.1016\/j.jaci.2009.07.017"},{"key":"10.3238\/arztebl.2017.0489_ref52","doi-asserted-by":"crossref","unstructured":"Leibfried M, Kovary A: C1 esterase inhibitor (Berinert) for ACE inhibitor-induced angioedema: two case reports. J Pharm Pract 2016; pii: 0897190016677427 (Epub ahead of print).","DOI":"10.1177\/0897190016677427"},{"key":"10.3238\/arztebl.2017.0489_ref53","unstructured":"Zuberbier T, Aberer W, Brockow K, et al.: Classification and diagnosis of urticaria: German language version of the international S3-guideline. Allergo J 2011; 20: 249\u201358."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:28:57Z","timestamp":1638872937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0489","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}